🕵️ Lakefront Biotherapeutics NV ($LKFT)

SEC insider & ownership activity, last 12 months · CIK 1421876 · every row links its SEC filing

Insiders were quiet over the last 12 months – no open-market buys or sells. ECOR1 Capital, LLC added 11.8% → 13.2%; Oleg Nodelman added 11.8% → 13.2%. No red-flag 8-Ks in the window.

Insider flow

0 buyers, $0 (0 lots) · 0 sellers, $0 (0 lots)

No open-market insider transactions in the last 12 months.

5%+ holders

HolderStakeClassScheduleEvent
Gilead Therapeutics A1 Unlimited Company 29.9% 13DJan 7, 2025 filing ↗
Gilead Sciences, Inc. 29.9% 13DJan 7, 2025 filing ↗
ECOR1 Capital, LLC 13.2% 13DJul 24, 2025 filing ↗
Oleg Nodelman 13.2% 13DJul 24, 2025 filing ↗
ECOR1 Capital Fund Qualified, L.P. 12.4% 13DJul 24, 2025 filing ↗
TANG Capital Management, LLC 8.4% 13GOct 29, 2025 filing ↗
Kevin Tang 8.4% 13GOct 29, 2025 filing ↗
Kevin Tang 7.5% 13DFeb 7, 2025 filing ↗
TANG Capital Management, LLC 7.5% 13DFeb 7, 2025 filing ↗
Madison Avenue International LP 5.5% 13GJun 23, 2026 filing ↗
Madison Avenue Partners, LP 5.5% 13GJun 23, 2026 filing ↗
EMAI Management, LLC 5.5% 13GJun 23, 2026 filing ↗
Madison Avenue GP, LLC 5.5% 13GJun 23, 2026 filing ↗
Caraway Jackson Investments LLC 5.5% 13GJun 23, 2026 filing ↗
Eli Samaha 5.5% 13GJun 23, 2026 filing ↗
TANG Capital Partners, LP 5.0% 13GOct 29, 2025 filing ↗

Planned insider sales (Form 144)

No sale notices filed in the last 12 months.

Material events (8-K)

No 8-K filings in the last 12 months.